Sarcoma Foundation of America Announces 2019 Research Grant Awards

DAMASCUS, Md. – June 27, 2019 – The Sarcoma Foundation of America (SFA), an organization dedicated to increased research and awareness for sarcoma, today announced that it has awarded three quarters of a million dollars in research funds to deserving scientists as part of its 2019 SFA Research Grant program. Fifteen research grants, each worth $50,000, have been awarded to researchers who have made it their mission to study sarcoma, a cancer that arises in the body’s soft tissue and bone. All proposals are peer reviewed by members of the SFA Medical Advisory Board who award the grants to the best, most promising research toward the cure for sarcoma.

Since its inception, the SFA has invested more than $9.5 million in sarcoma research through its national grant program and collaborative research projects. More information on SFA’s research program can be found at

Sarcoma Foundation of America 2019 Research Grants

Dr. Richard and Valerie Aronsohn Memorial Research Award
Annette Duensing, MD
University of Pittsburgh Cancer Institute
“Dissecting DNA damage and repair pathways in leiomyosarcomas: Improving therapy by understanding biology”

Zach Cohen Memorial Research Award
Seth Pollack, MD
Fred Hutchinson Cancer Research Center
“Modulation of Cold Sarcoma Microenvironments to Enable T Cells in Experimental Systems”

Zach Cohen Memorial Research Award
Jacob Scott, MD
Cleveland Clinic
“Uncovering polygenic signatures of Ewings Sarcoma drug sensitivity during the evolution of resistance”

Zach Cohen Memorial Research Award
Lai Man Natalie Wu, PhD
Cincinnati Children’s Hospital Medical Center
“Single-cell transcriptomics and epigenomics to identify tumor-microenvironment Interactions for targeted treatment of MPNST”

Jay Vernon Jackson Memorial Research Award
Joshua Waterfall, PhD
Institut Curie (France)
“Intratumoral heterogeneity in dedifferentiated liposarcoma”

Christopher Langbein Research Award
Roberto Perris, PhD
Universita degli Studi di Parma (Italy)
“Immunotargeting of the prognostic NG2/CSPG4 cell surface proteoglycan in soft-tissue histotypes”

Spring for Sarcoma York, PA, Research Award
Claudio Brancolini, PhD
University of Udine (Italy)
“Resetting the epigenetic addiction in leiomyosarcomas: a therapeutic perspective”

Spring for Sarcoma York, PA, Research Award
Jlenia Guarnerio, PhD
Cedars-Sinai Medical Center
“Switching the tumor immune microenvironment from “cold” to “hot” in UPS”

Pittsburgh Cure Sarcoma Research Award
David Scadden, MD
Massachusetts General Hospital
“Identification of molecular targets promoting differentiation and loss of self renewal in osteosarcoma”

Pittsburgh Cure Sarcoma Research Award
Juan Manuel Schvartzman, MD, PhD
Memorial Sloan Kettering Cancer Center
“Deciphering the effects of IDH mutations on chromatin and differentiation in chondrosarcoma”

STL Cure Sarcoma Research Award
Eleanor Chen, MD, PhD
University of Washington
“Identify and characterize therapeutic targets against cancer stemness and chemotherapy resistance in rhabdomyosarcoma”

Race to Cure Sarcoma Research Award
Enrique De Alava, MD, PhD
Instituto de Biomedicina de Sevilla (Spain)
“Translational assessment of predictive factors of response of Ewing sarcoma to genotoxic therapy”

Race to Cure Sarcoma Research Award
Andrew Futreal, PhD
MD Anderson Cancer Center
“Immune profiling of pleomorphic rhabdomyosarcoma”

Race to Cure Sarcoma Research Award
David Shultz, MD, PhD
Princess Margaret Cancer Centre (Canada)
“Characterizing the Genetic Landscape of Radiation Associated Cutaneous Angiosarcomas”

Sarcoma Foundation of America Research Award
Philip Hinds, PhD
Tufts University
“Enabling anti-tumor immunity in osteosarcoma through manipulation of the pRb pathway”


About the Sarcoma Foundation of America
The Sarcoma Foundation of America (SFA), a 501(c)(3) nonprofit charitable organization, is an advocate for increased research to find new and better therapies with which to treat patients with sarcoma. The organization raises money to privately fund grants for sarcoma researchers and conducts education and advocacy efforts on behalf of sarcoma patients. For more information, please visit

 About Sarcoma
Sarcoma is a rare cancer in adults (1 percent of all adult cancers) but rather prevalent in children (about 20 percent of all childhood cancers). At any one time, 50,000 patients and their families are struggling with sarcoma. Every year, nearly 16,000 new cases are diagnosed and more than 6,000 people die from the disease.


Contact Information: 

Lori Hoffman
(301) 253-8687